Our future work will focus on the mechanism by which OCRL1 acts at junctions, to identify proteins that might be inhibited or activated to compensate for loss of OCRL1 in Lowe Syndrome. The gene discussed is OCRL; the disease is oculocerebrorenal syndrome.